President Donald Trump signed an executive Saturday that aims to accelerate research and approval of psychedelic-based therapies for conditions such as PTSD.
An upcoming executive order is intended to accelerate research into the compounds’ efficacy in treating PTSD, depression and other mental health problems, officials said.
Details on the announcement were not immediately clear, but it comes as the president is expected to sign an order that creates a new initiative to address drug addiction.
The White House has failed to achieve either its strategic or its tactical goals in Minnesota.
AI:Jamelle Bouie argues that Minneapolis serves as a pivotal historical turning point comparable to Gettysburg for President Trump’s administration, claiming the White House has failed to meet its strategic and tactical objectives in Minnesota. This perspective attempts to frame current unrest and federal actions in the state as an inevitable crisis rather than a localized enforcement issue.Open
"I would say (both are) equally at fault," West told NewsNation.
AI:Rep. Nolan West stated that leadership on both sides shares responsibility for failing to act sooner, suggesting that earlier intervention could have prevented loss of life.Open